Research Project
Project Title: |
Phase 3, randomized, double-blind, active versus control cycle to evaluate the safety and efficacy of CCX168 (Avacopan) in patients with cytoplasmic antineutrophil associated vasculitis (ANCA) in combination with rituximab ofosfamide / azathioprine. |
Project Type: |
Clinical Trial, Enrolment ongoing |
Disease group(s): |
Immune glomerulopathies |
Project Summary: |
Phase 3, randomized, double-blind, active versus control cycle to evaluate the safety and efficacy of CCX168 (Avacopan) in patients with cytoplasmic antineutrophil associated vasculitis (ANCA) in combination with rituximab ofosfamide / azathioprine. |
Lead principal investigator(s): |
Dario Roccatello, Turin |
Project Period: |
09/2022 - 12/2060 |
Sponsors: |
Industry |
ClinicalTrials.gov: |
NCT02994927 |
« Back to research page